Retatrutide has emerged as a new treatment in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating https://nicolasmmgi110406.canariblogs.com/retatrutide-a-promising-new-treatment-for-obesity-51077154